319 related articles for article (PubMed ID: 12357500)
41. Primary non-Hodgkin's lymphoma of the common bile duct.
Maymind M; Mergelas JE; Seibert DG; Hostetter RB; Chang WW
Am J Gastroenterol; 1997 Sep; 92(9):1543-6. PubMed ID: 9317083
[TBL] [Abstract][Full Text] [Related]
42. [A primary malignant lymphoma of the appendix].
Shimada K; Sato M; Haruyama S; Ichikawa T; Aono G; Ohara T; Ando Y; Abe R; Nozawa Y; Wakasa H
Gan No Rinsho; 1990 Sep; 36(11):2086-91. PubMed ID: 2232177
[TBL] [Abstract][Full Text] [Related]
43. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
[TBL] [Abstract][Full Text] [Related]
44. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
Sumi M; Ichikawa N; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2007 Jul; 48(7):571-5. PubMed ID: 17695307
[TBL] [Abstract][Full Text] [Related]
45. Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma.
Morrison VA
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1651-8. PubMed ID: 18925856
[TBL] [Abstract][Full Text] [Related]
46. Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma.
Ferrari A; Luppi M; Lazzerini A; Potenza L; Cavallini GM; Torelli G
Lancet Oncol; 2006 Mar; 7(3):274. PubMed ID: 16510339
[No Abstract] [Full Text] [Related]
47. Richter's transformation of chronic lymphocytic leukemia.
Giardino AA; O'Regan K; Jagannathan JP; Elco C; Ramaiya N; Lacasce A
J Clin Oncol; 2011 Apr; 29(10):e274-6. PubMed ID: 21220587
[No Abstract] [Full Text] [Related]
48. Therapy of diffuse large B-cell lymphomas.
Pfreundschuh M
Eur J Cancer; 2009 Sep; 45 Suppl 1():386-7. PubMed ID: 19775641
[No Abstract] [Full Text] [Related]
49. [Non-Hodgkin's lymphoma of the bone, with reference to MRI findings following treatment].
Saito S; Hayashi K; Ohnoshi T; Kawashima K; Matsutomo S; Tagawa S; Mizuta J; Tada A; Ueno K; Kimura I
Gan To Kagaku Ryoho; 1993 Apr; 20(5):665-8. PubMed ID: 7682396
[TBL] [Abstract][Full Text] [Related]
50. Non-Hodgkin's lymphoma presenting as an endobronchial tumor: report of eight cases and literature review.
Solomonov A; Zuckerman T; Goralnik L; Ben-Arieh Y; Rowe JM; Yigla M
Am J Hematol; 2008 May; 83(5):416-9. PubMed ID: 18175356
[TBL] [Abstract][Full Text] [Related]
51. Long standing priapism as presentation of lymphoma.
Madeb R; Rub R; Erlich N; Hegarty PK; Yachia D
Am J Hematol; 2007 Jan; 82(1):87. PubMed ID: 17078020
[No Abstract] [Full Text] [Related]
52. Front-line management of diffuse large B cell lymphoma.
Cabanillas F
Curr Opin Oncol; 2010 Nov; 22(6):642-5. PubMed ID: 20811278
[TBL] [Abstract][Full Text] [Related]
53. Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.
Brusamolino E; Rusconi C; Montalbetti L; Gargantini L; Uziel L; Pinotti G; Fava S; Rigacci L; Pagnucco G; Pascutto C; Morra E; Lazzarino M
Haematologica; 2006 Apr; 91(4):496-502. PubMed ID: 16537117
[TBL] [Abstract][Full Text] [Related]
54. Differential therapy for diffuse large B-cell lymphoma with different cells of origin.
Murawski N; Pfreundschuh M
Onkologie; 2009 Dec; 32(12):711-2. PubMed ID: 20016230
[No Abstract] [Full Text] [Related]
55. Inappropriate antidiuretic hormone production in diffuse large B-cell lymphoma.
Kobayashi K; Yokote T; Akioka T; Takubo T; Tsuji M; Hanafusa T
Br J Haematol; 2008 Oct; 143(1):2. PubMed ID: 18513282
[No Abstract] [Full Text] [Related]
56. [Primary malignant lymphoma arising from the nipple and areolar area of the breast].
Nakane T; Yamane T; Shibata H; Aoyama Y; Hasegawa T; Sakamoto C; Nakamae H; Terada Y; Ohta K; Hino M
Rinsho Ketsueki; 2003 Nov; 44(11):1107-9. PubMed ID: 14689876
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
58. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
59. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP.
Lin PC; Hsiao LT; Poh SB; Wang WS; Yen CC; Chao TC; Liu JH; Chiou TJ; Chen PM
Ann Hematol; 2007 Feb; 86(2):95-100. PubMed ID: 17031689
[TBL] [Abstract][Full Text] [Related]
60. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.
Laurent C; Do C; Gascoyne RD; Lamant L; Ysebaert L; Laurent G; Delsol G; Brousset P
J Clin Oncol; 2009 Sep; 27(25):4211-6. PubMed ID: 19636007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
